Viral Hemorrhagic Fever Clinical Trials

Find Viral Hemorrhagic Fever Clinical Trials Near You

Development Of A Rapid Diagnostic Test To Identify Crimean-Congo Haemorrhagic Fever At The Point-Of-Care

Status: Recruiting
Location: See all (6) locations...
Intervention Type: Device
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

The goal of this medical device diagnostic evaluation study is to determine if this novel lateral flow device can detect Crimean-Congo Hemorrhagic Fever (CCHF) at the point of care in secondary health care clinics in Turkey. The main outcome is to determine the sensitivity and specificity of the tests for CCHF in samples of whole blood, serum and capillary blood compared to a gold-standard of PCR for participants that present at 4 endemic sites secondary health care clinics in Turkey in 492 adults who are suspected to have been infected with CCHF. The study aims to hopes to achieve at least the minimum required sensitivity of 90 % and specificity of 80 % as required by the WHO.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:

• Participants aged 18 years or older Suspected CCHF infection that requires a RT-PCR diagnosis and venous blood draw Willingness to comply with study procedures and consent to the study Presents at 1 of 4 listed sites

Locations
Other Locations
Turkey
Atatürk University
RECRUITING
Erzurum
Erzurum City Hospital
RECRUITING
Erzurum
Kastamonu Üniversitesi
RECRUITING
Kastamonu
Ondokuz Mayis University (OMU) Faculty of Medicine, Department of Clinical Microbiology and Infectious Diseases, Samsun
RECRUITING
Samsun
Sivas Cumhuriyet University
RECRUITING
Sivas
Tokat Gaziosmanpaşa University
RECRUITING
Tokat Province
Contact Information
Primary
Ravi Lad
ravi.lad@lstmed.ac.uk
151 705 3364
Backup
Ana Cubas Atienzar, PhD
Ana.CubasAtienzar@lstmed.ac.uk
151 705 3364
Time Frame
Start Date: 2026-05-04
Estimated Completion Date: 2027-09
Participants
Target number of participants: 492
Related Therapeutic Areas
Sponsors
Collaborators: Medical Research Council, MEDEX, Mologic Ltd
Leads: Liverpool School of Tropical Medicine

This content was sourced from clinicaltrials.gov